Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies

Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies

Type 2 diabetes mellitus (T2DM) is one of the most common chronic diseases worldwide. Several classes of hypoglycemic drugs are used to treat it, but various side effects limit their clinical use. Consequently, the search for new anti-diabetic agents remains an urgent task for modern pharmacology. I...

Full description

Bibliographic Details
Main Authors: Darya A. Pon’kina, Sergey O. Kuranov, Mariya K. Marenina, Yulia V. Meshkova, Nataliya A. Zhukova, Mikhail V. Khvostov, Olga A. Luzina, Tatiana G. Tolstikova, Nariman F. Salakhutdinov
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Pharmaceutics
Subjects:
bornyl derivatives
FFAR1 agonist
hypoglycemic activity
hepatoprotective effect
OGTT
diabetes mellitus
Online Access:https://www.mdpi.com/1999-4923/15/6/1670

Internet

https://www.mdpi.com/1999-4923/15/6/1670

Similar Items